Colgate-Palmolive (CL) Receives Consensus Rating of “Hold” from Analysts

Colgate-Palmolive (NYSE:CL) has earned an average recommendation of “Hold” from the seventeen brokerages that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a sell recommendation, twelve have assigned a hold recommendation and two have given a buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $69.85.

A number of research firms have weighed in on CL. Barclays set a $64.00 target price on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Monday, July 30th. UBS Group set a $71.00 target price on shares of Colgate-Palmolive and gave the stock a “buy” rating in a research report on Wednesday. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Monday, July 2nd. Macquarie lowered shares of Colgate-Palmolive from an “outperform” rating to a “neutral” rating and cut their target price for the stock from $74.00 to $65.00 in a research report on Monday, July 30th. Finally, Atlantic Securities began coverage on shares of Colgate-Palmolive in a research report on Thursday, September 20th. They set a “neutral” rating and a $71.00 target price for the company.

In other news, VP Philip G. Shotts sold 462 shares of the company’s stock in a transaction dated Tuesday, September 11th. The shares were sold at an average price of $67.05, for a total transaction of $30,977.10. Following the completion of the transaction, the vice president now owns 41,250 shares of the company’s stock, valued at $2,765,812.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Henning I. Jakobsen sold 1,015 shares of the company’s stock in a transaction dated Tuesday, September 11th. The shares were sold at an average price of $67.05, for a total transaction of $68,055.75. Following the transaction, the chief financial officer now directly owns 36,193 shares of the company’s stock, valued at approximately $2,426,740.65. The disclosure for this sale can be found here. Insiders have sold 395,779 shares of company stock valued at $26,108,856 in the last ninety days. 1.02% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in CL. TIAA FSB grew its stake in Colgate-Palmolive by 2.6% during the third quarter. TIAA FSB now owns 74,773 shares of the company’s stock worth $5,006,000 after buying an additional 1,903 shares during the last quarter. Capital City Trust Co. FL grew its stake in Colgate-Palmolive by 3.1% during the third quarter. Capital City Trust Co. FL now owns 50,977 shares of the company’s stock worth $3,413,000 after buying an additional 1,513 shares during the last quarter. LGT Capital Partners LTD. grew its stake in Colgate-Palmolive by 12.3% during the third quarter. LGT Capital Partners LTD. now owns 973,380 shares of the company’s stock worth $65,168,000 after buying an additional 106,720 shares during the last quarter. Oakbrook Investments LLC bought a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $23,159,000. Finally, Aperio Group LLC grew its stake in shares of Colgate-Palmolive by 6.1% during the third quarter. Aperio Group LLC now owns 547,977 shares of the company’s stock valued at $36,687,000 after purchasing an additional 31,588 shares during the last quarter. 74.95% of the stock is owned by institutional investors and hedge funds.

NYSE:CL traded up $2.08 during trading hours on Friday, reaching $64.72. The company’s stock had a trading volume of 170,043 shares, compared to its average volume of 3,644,756. The stock has a market capitalization of $55.14 billion, a PE ratio of 22.71, a P/E/G ratio of 2.91 and a beta of 0.72. Colgate-Palmolive has a one year low of $61.28 and a one year high of $77.91. The company has a current ratio of 1.06, a quick ratio of 0.74 and a debt-to-equity ratio of -34.49.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 27th. The company reported $0.77 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.77. The firm had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.91 billion. Colgate-Palmolive had a net margin of 13.97% and a return on equity of 2,494.79%. Colgate-Palmolive’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.72 earnings per share. On average, sell-side analysts forecast that Colgate-Palmolive will post 3 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 15th. Stockholders of record on Friday, October 19th will be given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.60%. The ex-dividend date of this dividend is Thursday, October 18th. Colgate-Palmolive’s dividend payout ratio is currently 58.54%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Featured Article: How Buying a Call Option Works

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply